ALBIREO

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-11-03
Last Posted Date
2017-03-22
Lead Sponsor
Albireo
Target Recruit Count
190
Registration Number
NCT01007123
Locations
🇺🇸

Albireo Investigative Site, La Crosse, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath